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ABSTRACT: One of the major challenges in drug design is to identify
compounds with potential toxicity toward target cells, preferably with
molecular-level understanding of their mode of action. In this study, the
antitumor property of a ruthenium complex, mer-[RuCl3(dppb)(VPy)]
(dppb =1,4-bis(diphenylphosphine)butane and VPy = 4-vinylpyridine)
(RuVPy), was analyzed. Results showed that this compound led to a
mortality rate of 50% of HEp-2 cell with 120 ± 10 μmol L−1, indicating
its high toxicity. Then, to prove if its mode of action is associated with its
interaction with cell membranes, Langmuir monolayers were used as a
membrane model. RuVPy had a strong eﬀect on the surface pressure
isotherms, especially on the elastic properties of both the zwitterionic
dipalmitoylphosphatidylcholine (DPPC) and the negatively charged
dipalmitoylphosphatidylglycerol (DPPG) phospholipids. These data
were conﬁrmed by polarization-modulated infrared reﬂection−absorption spectroscopy (PM-IRRAS). In addition, interactions
between the positive group from RuVPy and the phosphate group from the phospholipids were corroborated by density
functional theory (DFT) calculations, allowing the determination of the Ru complex orientation at the air−water interface.
Although possible contributions from receptors or other cell components cannot be discarded, the results reported here
represent evidence for signiﬁcant eﬀects on the cell membranes which are probably associated with the high toxicity of RuVPy.
1. INTRODUCTION
The biological activity of Ru complexes as antitumor agents was
ﬁrst described by Dwyner and co-workers, who attributed the
eﬀect to the ligand 1,10-phenanthroline or related bases.1,2 Ru
complexes interact with proteins and lipids located on cell
surfaces through noncovalent interactions, but the most
relevant parameters for such activity are coordination and
state of oxidation.3,4 The antitumor activity of Ru complexes
containing heterocyclic nitrogenous ligands are probably due to
noncovalent interaction between aromatic cyclic ligands and
biomolecules (e.g., for DNA intercalation).5 The interest in Ru
compounds has decreased after the breakthrough with the
discovery of antitumor activity of Pt complexes (cisplatin),
which is ascribed to their ability to interact with DNA
molecules after entering the cells.6 Nevertheless, Pt complexes
have been found to exhibit low speciﬁcity toward cancer cells,
being highly toxic also for healthy cells. This has brought
further motivation to revisit the possible use of Ru compounds,
whose ability to coordinate with diﬀerent ligands was explored
to obtain antitumor agents with the same eﬃciency of cisplatin,
but with lower toxicity and antimetastatic activity.7 This low
cytotoxicity can be achieved because ruthenium mimics iron in
binding biological molecules such as serum proteins.8 The
antimetastatic activity has not yet been elucidated, but it has
been suggested that the low level of oxygen in the tumor
environment could transform Ru III into the more reactive Ru
II, which can bind to various biomolecules, including DNA.9 It
seems that the mechanism of action for Ru complexes diﬀers
from those well established for Pt complexes,10−16 involving
four contributions:17 (i) electrostatic binding, (ii) external
binding, (iii) groove binding, and (iv) intercalative binding.
Current interest in the design of new ruthenium complexes
as therapeutic agents focuses on the role that phosphine ligands
play in determining the chemical properties, and hence
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biological activity of these complexes.18,19 Phosphine complexes
of various transition metals (Au, Ag, Cu, Ru, Rh, Pt, Pd) have
been evaluated as potential antitumor agents in various human
tumor cell lines.20−25 For Au complexes, for instance, activity
has been attributed to the presence of the phosphine ligands,
since similar complexes without them had a very low activity.26
trans-Phosphine amine complexes investigated by Navarro-
Ranninger et al. were found to induce apoptosis in both
cisplatin sensitive and resistant cell lines, representing a
promising means of treating cancers where cisplatin is
inactive.27 One of the earliest works of biological activity with
biphosphine ligand coordinated to ruthenium complexes was
performed with fac-[RuCl3(NO)(dppf)] (dppf =1,1′-bis-
(diphenylphosphino)ferrocene), which yielded a highly potent
compound with IC50 = 10 ± 3 μmol L
−1 in MDA-MB-231 cell
line, a value that is lower than those observed for the RuCl3NO·
2H2O precursor, free dppf ligand and cisplatin.
20 The cytotoxic
activity of mer-[RuCl3(dppb)H2O] (dppb =1,4 bis-
(diphenylphospine)butane) against MCF-7, TK-10, and
UACC-62 human tumors was of the same order of magnitude
as that of the clinical drugs etoposide and colchicines.21
Therefore, coordination to biphosphine ligands to ruthenium
complexes with oxidation state +2 or +3 improved the cytotoxic
activity.
In this study, we investigated the interaction of mer-
[RuCl3(dppb)(VPy)] (VPy = 4-vinylpyridine), RuVPy, with
human laryngeal carcinoma cells as well as artiﬁcial membranes.
For the latter, molecular-level information could be obtained
with RuVPy in Langmuir monolayers simulating the membrane
environment. The interaction between RuVPy and phospho-
lipid monolayers was also explored in terms of change in
morphology using Brewster angle microscopy (BAM) and in
the spectroscopic properties with polarization modulated-
infrared reﬂection absorption spectroscopy (PM-IRRAS).
2. MATERIALS AND METHODS
2.1. Materials. All chemicals used were of reagent grade or
comparable purity. All solvents were purchased from Merck.
mer-[RuCl3(dppb)(VPy)] was synthesized through a well-
established route for similar complexes.28,29 The ligands 1,4-
bis(diphenylphosphino)butane (dppb) and 4-vinylpyridine
were used as received from Aldrich. The phospholipid with
chirality levogero L-dipalmitoylphosphatidylcholine (referred to
as DPPC hereafter) and a racemic mixture of the rac-
dipalmitoylphosphatidylglycerol (DPPG hereafter) were ac-
quired from Avanti Polar Lipids and used without further
puriﬁcation. The electronic absorption spectra for compounds
solution (0,5 mmol L−1) were recorded in a Varian
spectrophotometer model Cary 50 Bio using a quartz cell,
light path 5 mm.
2.2. Cell Viability Assays. The biological activity was
tested using human laryngeal carcinoma HEp-2 cell (ATCC
CCL 23) and VERO (African green monkey kidney) control
cell lines. The latter were cultured in Iscove’s modiﬁed
Dulbecco’s medium (IMDM, Sigma, St. Louis, MO)
supplemented with 10% fetal bovine serum, 10000 IU mL−1
penicillin and 10 mg mL−1 streptomycin in a humidiﬁed
environment with 5% CO2 at 37 °C. Cells were maintained at
37 °C in a moist environment as a sub conﬂuent monolayer
and were routinely sub cultured twice a week. For the assays,
96-well plates were used, and in each well 1 × 105 cells were
incubated for 24 h at 37 °C in 5% CO2. Then, the medium was
removed and the cells were incubated for 24 h with diﬀerent
concentrations of RuVPy (5−250 μg mL−1) dissolved in
DMSO and diluted using the culture medium with a ﬁnal
DMSO concentration of 1%. Controls were always treated with
the same amount of DMSO as used in the corresponding
experiments. After the incubation period, the cells were washed
with PBS and fresh medium was added. Following this
treatment, the cells were kept at 37 °C, 5% CO2, and 95%
air for an additional 48 h. Cell viability was assessed using a
colorimetric assay, in the presence of 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT, Sigma), based on
the cellular conversion of a tetrazolium salt into formazan.30 50
μL of 1 mg mL−1 solution of MTT in IMDM medium were
added to each well, followed by 3 h incubation at 37 °C, 5%
CO2, 95% air. The MTT solution was removed, and 50 μL of
ethanol and 150 μL of a solution containing PBS and
isopropanol (1:1) were added to each well in order to
solubilize the crystals formed. The absorbance of each well was
read on a microplate reader (Versamax, Molecular Device) at
550 nm, being proportional to the number of living cells.
Experiments were performed in sextuplicate for each
concentration of RuVPy and for the control cells. The results
were expressed as the mean ± standard deviation and the
survival index (Supporting Information) was calculated as
follows: Survival ratio (%) = (Adrug/Acontrol) × 100%, where A =
absorbance.31 The mean inhibitory concentration, IC50, was
taken as the concentration that caused 50% inhibition of cell
viability, being calculated using Calcusyn,32 the multiple drug
eﬀect analysis software.
2.3. Computational Simulations. The quantum chemical
calculation for the RuVPy molecule, whose structure is shown
in Figure 3, was carried out using density functional theory
(DFT) with B3LYP/lanl2dz implemented on GAUSSIAN
package.33 The optimized geometrical structure of RuVPy
complex was used to infer the conformation that RuVPy should
adopt at the air−water interface, based on the area per molecule
for a condensed monolayer from π−A isotherms. In general,
this area was associated with the geometrical triangle area
among atoms H67, H55 and C75 (Figure 3A). The
electrostatic potential map was visualized using the Molekel
5.3 program,34 which allowed one to identify the higher density
electronics groups.
2.4. Langmuir Monolayers. The complex RuVPy and lipid
molecules were cospread at the air−water interface. Langmuir
monolayers were produced by spreading chloroform solutions,
for RuVPy and DPPC, or 4:1 (v:v) chloroform:methanol
solutions for DPPG, onto the surface of a PBS buﬀer (pH 7.4,
150 mM NaCl) in a Mini KSV Langmuir trough (KSV,
Finland) equipped with a Wilhelmy plate as surface pressure
sensor. Mixed (RuVPy/DPPC and RuVPy/DPPG) monolayers
were prepared by mixing diﬀerent volumes of RuVPy and
phospholipid stock solutions at 1 mM of concentration.
Appropriate volumes were mixed to render the concentrations
of RuVPy 10, 30, 50, 70 and 90% in mol. Aliquots of 40 μL of
these mixed solutions were then spread onto the PBS buﬀer
surface with a micrometric syringe. The solvent was allowed to
evaporate for ca. 10 min before monolayer compression. The
surface pressure versus area per molecule (π-A) isotherms were
recorded with symmetrical compression of the monolayers with
two barriers at a constant speed of 10 mm min−1 (∼5 Å2
molecule−1 min−1). The experiments were performed at 20 ± 1
°C and the isotherms represent the average of at least two
measurements for each concentration of the Ru complex. The
cospreading method was used here because RuVPy is not
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soluble in water. Furthermore, the amount of drug molecules
interacting with the phospholipid is known, which would not be
the case if RuVPy was adsorbed from the subphase.
Brewster Angle Microscopy. A BAM 2 Brewster angle
microscope from Nanoﬁlm Technology, equipped with a 30
mW laser emitting p-polarized light at 690 nm, allowed imaging
the surface with a 2 μm resolution. The reﬂected light at the
Brewster angle (52.16°) was detected by means of a CCD
camera and recorded with image processing software to
improve contrast. The principles of detection in a BAM
microscope are described in ref 35. When a Langmuir ﬁlm is
formed, the refractive index at the air/water interface is slightly
changed, yielding reﬂected light toward the camera. An image
of the interfacial ﬁlm structure is formed by the contrast of the
regions with lower molecular concentration of the ﬁlm (dark
regions, without reﬂection) and spots where the water surface is
covered with higher molecular concentration of the ﬁlm (bright
regions, reﬂection).
Polarization Modulation Infrared Reﬂection Absorption
Spectroscopy (PM-IRRAS). PM-IRRAS measurements were
taken with a KSV PMI 550 instrument (KSV instrument Ltd.,
Helsinki, Finland). The experimental setup used was similar to
that described by Geraldo and co-workers.36 The Langmuir
trough is placed in a way that the light beam reaches the
monolayer at a ﬁxed incidence angle of 80°, at which the
intensity is maximum with a low level of noise. The incoming
light is continuously modulated between s- and p-polarization at
a high frequency, which allows for the simultaneous measure-
ment of the spectra for the two polarizations. The diﬀerence
between the spectra provides surface-speciﬁc information, and
the sum gives the reference spectrum. The eﬀect from water
vapor is reduced with the simultaneous measurements. The
same equipment and conditions were used for characterizing
Langmuir−Blodgett (LB) ﬁlms deposited onto Si substrates,
obviously with no PBS background.
2.5. Langmuir−Blodgett Deposition. LB ﬁlms were
transferred from Langmuir monolayers at a pressure of 30 mN
m−1, which is close to the biomembrane pressure.37 Z-type LB
ﬁlms with 3 layers were deposited onto Si substrates. Transfer
ratios close to 1.0 were obtained by varying the dipping speed
from 0.5 mm/min (RuVPy monolayer) to 5 mm/min (pure
phospholipid and mixed monolayers).
3. RESULTS AND DISCUSSION
3.1. Toxicity of RuVPy. The cytotoxic activity of RuVPy
against human laryngeal carcinoma cell lines, HEp-2, and
control cell line VERO, was examined over a period of 24 h of
incubation. The MTT colorimetric assay was used to analyzed
cell viability and expressed as IC50. Figure 1 shows the Hep-2
survival curves for diﬀerent concentrations of RuVPy, which
was eﬀective against laryngeal cancer cells with an IC50 value of
120 ± 10 μmol L−1. It also exhibited cytotoxic activity against
normal VERO cells, with IC50 = 67 ± 7 μmol L
−1 indicating
that this complex is not speciﬁc for tumor cells. In comparison,
a much higher dose (306.9 μmol L−1) was necessary for
reaching a high cell mortality of human carcinoma cells when
mer-[RuCl3(dppb)H2O], a ruthenium complex with similar
structure to RuVPy, was used.21
A possible mechanism to explain the cytotoxicity of RuVPy is
the one reported for Ru(III) complexes, referred to as pro-
drugs. Within this mechanism, the anticancer activity is ascribed
to the complex reduction to Ru(II) species, which are more
reactive and likely to be involved in ligand exchange reactions,
being therefore able to interact with target molecules
eﬃciently.38,39 In a cell membrane the complex of RuVPy
could be reduced to Ru(II), but for our model membrane we
found that this does not occur. This conclusion was based on
UV−vis spectra taken for RuVPy mixed with phospholipids,
which are shown in Figure S1 of the Supporting Information.
The interaction with the cell membranes should also be crucial
because metal complexes are known to induce abnormalities
such as membrane blebbing40 and mitochondrial damage,
which depend on the plasma membranes. Furthermore, the
ability of metal complexes to diﬀuse into the cell is determined
by their interaction with the membrane lipids.41 Indeed, on
these interactions depends the amount of metal to be
administered because the ruthenium complex is lodged in the
lipophilic layer.42 The lipophilic character of Ru complexes has
been proven important for the cytotoxicity in a comparison
between a complex containing a pyrimidine deoxyribo or
ribonucleoside l igand and another with a trans-
[RuCl4(DMSO)2]
− Na+ precursor.42
3.2. Interaction with Cell Membrane Models. The high
toxicity of RuVPy for both human laryngeal carcinoma cell
lines, HEp-2cells, and VERO line (control cells) points to a
mode of action that may depend strongly on the interaction
with the core of cell membranes, for speciﬁc receptors in the
membrane would not be required. Because mimicking the
whole cell membranes is not feasible when one wishes to obtain
precise molecular-level information, here we used phospholipid
Langmuir monolayers to represent the membrane. In order to
take into account the importance of surface charge, use was
made of a zwitterionic (DPPC) and an anionic (DPPG)
phospholipids, and the eﬀects from incorporating RuVPy were
studied with several methods. We evaluated and systematically
compared the monolayer behavior of DPPC and DPPG
individually as a function of complex concentration by
measuring surface pressure−area (π−A) isotherms.
3.2.1. Surface Pressure Isotherms. The surface pressure
isotherm for RuVPy monolayer over PBS buﬀer subphase is
presented in Figure 2. There is no coexistence of liquid-
expanded (LE) and liquid-condensed (LC) phases, and the
limiting area, taken from extrapolating the curve at the
condensed state to zero surface pressure, is ∼55 Å2. The
inset brings the compressional modulus, Cs
−1, deﬁned as Cs
−1 =
−A(∂π/∂A)43 at constant temperature. According to the
Figure 1. Eﬀect of RuVPy on the survival index of HEp-2. Cells were
treated for diﬀerent RuVPy concentrations for 24 h. Each column
represents the mean ± SD for two experiments, each performed in
sextuplicate.
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deﬁnition of Davies and Rideal,44 the RuVPy monolayer is
mostly in the liquid-condensed phase, which means Cs
−1 values
are between 100 and 250 mN m−1. The π−A isotherms for
pure DPPC and DPPG are consistent with the literature.45
RuVPy was incorporated in DPPC or DPPG monolayers by
cospreading, with concentrations ranging from 10 to 90% in
mol, which means 100 to 900 μmol L−1. These values were
chosen to match those employed in the cytotoxic study. The
incorporation of RuVPy drastically aﬀected the DPPC and
DPPG monolayers, especially their elasticity (Figure 2). The
eﬀect on the plateau region, correspondent to the coexistence
of LE−LC phases depends on the RuVPy concentration. For
10% of RuVPy in DPPC monolayers, the plateau (LE to LC) is
still observed, but at 7 mN m−1, with the limiting area per
molecule being shifted to 62 Å2, higher than for pure DPPC.
With RuVPy concentrations from 30 to 70% the plateau was no
longer observed. Also worth mentioning is the decrease in Cs
−1
for these monolayers, especially at 25−30 mN m−1 (pressure
corresponding to the lipid packing in a cell membrane). Cs
−1
decreased with increasing concentration of RuVPy, i.e., the ﬁlm
became more ﬂuid. For 90:10% in mol of RuVPy:DPPC, the
surface pressure isotherm is similar to that of pure RuVPy, as
one should expect, while Cs
−1 was higher than for pure RuVPy.
The overall behavior departs from the additive rule for a binary
mixture,46 which means that some molecular-level interaction
takes place between RuVPy and DPPC.
The thermodynamic parameters of mixed RuVPy/DPPC
monolayers at the air−liquid interface, such as excess area
(ΔAE), excess free energy (ΔGE) and free energy of mixing
(ΔGM), were calculated for distinct surface pressures (π = 1, 3,
5, 10, 15, 20, 25, and 30 mN m−1) to better explore miscibility
(Figure S2), using eqs 1−4
Δ = − = − +A A A A X A X A( )E exp 12 exp 1 1 2 2 (1)
∫ ∫π
π
Δ = − = − +
π π
G A A A X A X Ad ( )
d
E
0
exp 12
0
exp 1 1 2 2
(2)
Δ = Δ + ΔG G GM E ID (3)
Δ = +G RT X X X X( ln ln )ID 1 1 2 2 (4)
where A1 and A2 denote the mean molecular area (mma) of
each single (pure) system of species 1 and 2, respectively, A12 is
the observed mma for their mixture, and the molar fractions of
the compounds 1 and 2 are represented as X1 and X2; R is the
gas universal constant, and T is the absolute temperature.46−48
Figure S2a−e in the Supporting Information shows the eﬀects
from incorporation of RuVPy. For low π (1−15 mN m−1), ΔGE
is positive suggesting predominant repulsive interactions,49
except for the 90:10 RuVPy:DPPC ratio, for which ΔGE was
always negative. At higher surface pressures, ΔGE becomes
negative and therefore attractive interactions between mole-
cules of the distinct components predominate. In fact, ΔGE was
increasingly negative as the surface pressure increased,
indicating that the degree of molecular interaction was
enhanced by rearranging the molecules at the interface.46
This same behavior was observed in the thermodynamic study
of mixed monolayers with DPPC with dioleoyltrimethylammo-
nium propane (DoTAP) at the air−water interface, pointing to
associative interactions especially at higher mole fractions of
DoTAP.49 The free energy of mixing, ΔGM, was negative under
all conditions studied for mixed RuVPy/DPPC monolayers, as
shown in Figure S2e in the Supporting Information. Therefore,
the mixed ﬁlms were more stable than the monolayers of neat
compounds, and the maximum stability was obtained for 50
and 70% of RuVPy at π = 30 mN m−1, for which ΔGM = −3.49
and −3.61 kJ mol−1, respectively. These observations are
consistent with data in the literature. In the mixed system
formed by DPPC and a terpenoid molecule, trans-dehydroc-
rotonin (t-DCTN), ΔGE was positive and ΔGM was negative.
Therefore, the insertion of t-DCTN into the phospholipid
monolayer resulted in stable ﬁlms. Since the same behavior was
observed for RuVPy, we may infer that a stable complex of
saturated phospholipids and RuVPy is formed at the air/water
interface.50
The surface pressure isotherm for pure DPPG in Figure 2B is
in agreement with those reported in the literature for a PBS
subphase,45 with a plateau at 8 mN m−1. The limiting area was
∼55 Å2/molecule and the collapse pressure was ∼70 mN m−1.
The isotherm was considerably aﬀected by addition of RuVPy,
as depicted in Figure S3a,b in the Supporting Information.
Upon adding RuVPy the LE-LC coexistence phase was
extinguished and, for π values higher than 27 mN m−1, the
area per molecule was smaller than for pure DPPG. According
to the Cs
−1 values, the mixed monolayers are less compressible
than their components separately. Figure S3d shows positive
ΔGE for π between 5 and 25 mN m−1, except for 90% of
RuVPy, thus indicating repulsive interactions between the
molecules. At π = 30 mN m−1, the excess free energy was
negative, probably because the degree of molecular interaction
was enhanced by packing the molecules and this led to
Figure 2. π−A isotherms for (A) RuVPy/DPPC and (B) RuVPy/DPPG mixed monolayers in diﬀerent molar ratios (indicated in the inset) spread
on PBS buﬀer at 20 °C. Inset: Compressibility modulus (Cs
−1) versus surface pressure for the pure compounds and mixtures.
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attractive interactions.48 Similarly to the mixed ﬁlms with
DPPC, the free energy of mixing ΔGM was negative, except for
10% RuVPy, and therefore the RuVPy/DPPG ﬁlms are more
stable than the corresponding monolayers of the neat
compounds. The maximum stability was measured for 90% of
RuVPy at π = 30 mN m−1, with ΔGM = −3.01 mol−1 kJ (Figure
S3e. The thermodynamic parameter of ΔGM shows that the
stability of RuVPy/phospholipid monolayers depends upon the
type of polar groups in the phospholipid, and ΔGM was found
to be more negative for the binary system with DPPC than for
DPPG. These observations are consistent with the literature,
being related to the charge of DPPG polar headgroup, which,
even at high concentration of RuVPy, appear to aﬀect the
miscibility of the binary system.51
Figure 3 shows the result of DFT calculations for RuVPy in
vacuum, which was used to infer the conformation of RuVPy at
the air−water interface, assuming this conformation to be
related to the minimum area per molecule in the π−A
isotherms. The extrapolated area for the condensed monolayer
of neat RuVPy was ca. 43 Å2, corresponding to the projected
area onto the surface established by the atoms H67, H55 and
C75. From this conformation and from the electrostatic
potential map for a neutral molecule of RuVPy in Figure 3B
obtained with DFT calculations, we could determine the groups
in contact with the aqueous surface for a condensed monolayer.
3.2.2. Morphological Analysis. Brewster angle microscopy
provided morphological information about the eﬀect of RuVPy
over phospholipid monolayers. Figure 4A for RuVPy shows no
domain formation. At 0 mN m−1, the monolayer is not uniform,
while upon compression, condensed regions coallesce resulting
in a very bright image. At 55 mN m−1 grooves appear, denoting
the collapse of the monolayer, consistent with the surface
pressure isotherm. Similar images were reported for bimetallic
ruthenium tris-bipyridine complexes [Ru(bpy)3Ph4Ru(bpy)L2]-
(PF6)4 (bpy = 2,2′-bipyridine, Ph = phenyl, L= 4,4′-dinon-1-
enyl-2,2′-bipyridine).52 For pure DPPC and DPPG mono-
layers, the images are consistent with the literature,53,54 and
typical domains for DPPC and DPPG monolayers over PBS
buﬀer are observed.
The incorporation of RuVPy aﬀects the morphology of a
DPPC monolayer, as indicated in Figure 5A. Domains started
to appear later in RuVPy/DPPC monolayer, with RuVPy
(10%), at 7 mN m−1. However, diﬀerences in the shape of the
domains are more evident, since at similar surface pressures
domains are smaller, with less deﬁned chirality. For the mixed
RuVPy/DPPG monolayer in Figure 5B, the domains observed
were also smaller. Hence, RuVPy prevents formation of large
domains of both DPPC and DPPG, probably owing to the
repulsive interactions between RuVPy and the phospholipids,
as inferred from the positive ΔGE in the thermodynamic
analysis (except for the ﬁlm containing 90% of RuVPy).
3.2.3. Spectroscopic Data. Figure 6 shows the PM-IRRAS
spectra for monolayers at 30 mN/m, which corresponds to the
pressure of a cell membrane,37 of neat RuVPy, DPPC, DPPG,
and the mixtures containing 10% of RuVPy (RuVPy/DPPC or
RuVPy/DPPG). A broad band at ca. 1675 cm−1, assigned to the
deformation of the vibrational mode of the liquid water at the
interface55 or restructuring of water molecules56 was observed
in all ﬁlms. This band was upward for neat DPPC and mixed
RuVPy/DPPG monolayers, but downward for neat RuVPy,
neat DPPG, and mixed RuVPy/DPPC monolayers. For RuVPy,
bands appeared at 1190 and 1275 cm−1 assigned to the P−
C6H5 stretching and CH2 scissors deformation of the dppb
ligand, respectively.57 Two strong bands appeared at ca. 2920
and 2850 cm−1, assigned to the asymmetric and symmetric C−
H stretches for CH2, respectively, coming from dppb and VPy
ligands57 and from the phospholipids DPPC or DPPG.58 The
ratio between the peak intensity of the symmetric C−H
stretches (Is, ca. 2850 cm
−1) and the asymmetric C−H stretches
(Ias, ca. 2920 cm
−1) increases when the order in the monolayer
Figure 3. (A) Structure and (B) electrostatic potential map of RuVPy in space (isovalue 0.05). Headline area between the H67, H55, and C75
atoms, which corresponds to the extrapolated area (43 Å2) for the condensed monolayer of neat RuVPy. The electrostatic potential is represented
with a color scale from red (−0.18 au) to blue (0.17 au).
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chains is decreased.59 Therefore, the incorporation of RuVPy
induced disorder since Is/Ias increased, probably because
RuVPy molecules aﬀected the packing of DPPC and DPPG
molecules, consistent with more ﬂuid monolayers as inferred
from the compressional modulus data. However, penetration of
RuVPy into the hydrophobic tail region must be limited since
the signal assigned to δ(CH2) vibrations for DPPC (1461
cm−1) and DPPG (1466 cm−1) was not strongly aﬀected by
RuVPy, at 1461 cm−1 for RuVPy/DPPC and RuVPy/DPPG.
The strongest eﬀects from incorporation of RuVPy occurred
for the headgroups of the phospholipids, particularly with the
PO2
− group. For neat DPPC monolayers the bands assigned to
the asymmetric stretching (νas-PO2
−) are observed at 1275 and
1240 cm−1, while the bands assigned to the symmetric
stretching (νs-PO2
−) appear at 1083 and 1030 cm−1. For the
RuVPy/DPPC mixed monolayer those bands were shifted to
1250 and 1222 cm−1 for νas-PO2
− and are completely vanished
in the case of νs-PO2
−. For DPPG the bands for νas-PO2
−
appeared at 1250 and 1216 cm−1, but vanished in the mixed
RuVPy/DPPG monolayer. The bands due to νs-PO2
− were
observed at 1100 and 1042 cm−1, and were shifted to 1093 and
1051 cm−1 for the mixed ﬁlm. Further changes induced by
interaction between RuVPy and the phospholipids were noted
in the spectra of parts A and B of Figure 6, which show bands at
ca. 1505 and ca. 1530 cm−1, assigned to C−N vibration and
CC stretching of the pyridine ligand, respectively.57 Since
these bands were absent in the RuVPy monolayer, their
presence points to interaction between RuVPy and DPPC or
DPPG.56,60 The band due to CO stretching in neat DPPC
appears at 1749 cm−1, being shifted to 1763 cm−1 for the mixed
RuVPy/DPPC monolayer. RuVPy also aﬀected the CO
stretching band from DPPG, but the shift was opposite to the
case of DPPC, from 1759 cm−1 for neat DPPG to 1738 cm−1 in
the mixed RuVPy/DPPG monolayer.
In summary, RuVPy induced strong changes in the
headgroup region of both DPPC and DPPG monolayers,
particularly in the PO group owing to change in hydration
and H-bonding with water molecules.36 There was practically
no penetration of RuVPy into the hydrophobic tails of the
phospholipids, even though the overall chain ordering
decreased. Scheme 1 depicts this interaction, where the
geometric arrangement was based on previous work with
reﬂectivity measurements on DPPC monolayers.61 The
assumed length for the RuVPy molecule close to 10 Å
corresponds to the arrangement of H67, H55, and C75 atoms
at the air/water interface. Particularly important was the
interaction with the negatively charged PO group of the
phospholipids, which should be expected from the computa-
tional simulations using DFT, for the electrostatic potential
map in Figure 3B indicates positive potential sites in the
pyridine group of RuVPy. In order to conﬁrm the adsorption of
the complex by polar heads of DPPC or DPPG molecules, LB
ﬁlms were transferred from Langmuir monolayers at a pressure
of 30 mN m−1. Similar PM-IRRAS results were obtained for the
LB ﬁlms of neat phospholipids, RuVPy and mixtures (Figure S4
a-d) in the Supporting Information, which conﬁrm the
Figure 4. π−A isotherms and BAM images for monolayers of (A)
RuVPy, (B) DPPC, and (C) DPPG spread on PBS buﬀer at 20 °C.
Figure 5. π−A isotherms and BAM images for monolayers obtained
with the mixture of (A) RuVPy/DPPC and (B) RuVPy/DPPG, with
RuVPy (10%), spread on PBS buﬀer at 20 °C.
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existence of molecular-level interactions between RuVPy and
the phospholipids.
■ CONCLUSIONS
Toxicity assays have indicated that the RuVPy complex is highly
toxic for both cancer and control cells, thus indicating a lack of
speciﬁcity that could be related to a mode of action depending
on the interaction with the cell membrane. We tested the latter
hypothesisin a very simpliﬁed wayby using Langmuir
monolayers as model membranes. The strong interaction was
conﬁrmed by the signiﬁcant changes in the packing and
morphology of both zwitterionic DPPC and anionic DPPG
monolayers. Furthermore, using PM-IRRAS we were able to
identify the interacting groups in the phospholipids and in
RuVPy, which was consistent with the electronic properties
obtained with DFT for RuVPy. Even though RuVPy is not able
to penetrate into the hydrophobic tail regions of the
phospholipid monolayers, the elastic properties of the latter
were changed considerably. If real membranes become more
ﬂuid upon interacting with RuVPy as the Langmuir monolayers
did, this is the likely mechanism for cell death, though we
cannot discard the importance of other cell components which
were not tested in our study.
■ ASSOCIATED CONTENT
*S Supporting Information
Spectroscopic data in the UV−vis region for RuVPy complex
and phospholipids/RuVPy mixtures, area per molecule plotted
against the relative concentration of RuVPy at various
pressures, and excess areas (ΔAE), excess free energies
(ΔGE), and free energy of mixing (ΔGM) for the mixtures,
along with the PM-IRRAS spectrum for LB ﬁlms deposited on
a Si substrate. This material is available free of charge via the
Internet at http://pubs.acs.org.
Figure 6. PM-IRRAS spectra for monolayers at 30 mN m−1 of the pure compounds and mixed RuVPy (10%) with DPPC (A) and DPPG (B).
Baseline is the line of the zero level of the PM-IRRAS signal.
Scheme 1. Idealized Organization of RuVPy and DPPC
Molecules at the Air/PBS Buﬀer Interfacea
aThe conﬁguration and length of RuVPy inserted in the DPPC
monolayer were obtained from the DFT calculations. The portion of
the DPPC molecule immersed into the aqueous subphase was taken
from reﬂectivity measurements by G. Fragneto et al.61.
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